Ebola vaccine trial proves 100% successful in Guinea

[muriel_volestrangler]

Source: The Guardian

A vaccine against Ebola has been shown to be 100% successful in trials conducted during the outbreak in Guinea and is likely to bring the west African epidemic to an end, experts say.

The results of the trials involving 4,000 people are remarkable because of the unprecedented speed with which the development of the vaccine and the testing were carried out.
...
When Ebola flared up in a village, researchers vaccinated all the contacts of the sick person who were willing – the family, friends and neighbours – and their immediate contacts. Children, adolescents and pregnant women were excluded because of an absence of safety data for them. In practice about 50% of people in these clusters were vaccinated.

To test how well the vaccine protected people, the cluster outbreaks were randomly assigned either to receive the vaccine immediately or three weeks after Ebola was confirmed. Among the 2,014 people vaccinated immediately, there were no cases of Ebola from 10 days after vaccination - allowing time for immunity to develop - according to the results published online in the Lancet medical journal (pdf). In the clusters with delayed vaccination, there were 16 cases out of 2,380.



Read more: http://www.theguardian.com/world/2015/jul/31/ebola-vaccine-trial-proves-100-successful-in-guinea

[blackspade]

1. I'd hate to be in the 'delayed' cluster......

[Elmer S. E. Dump]

3. Even in that cluster 99.3% survived.

[riversedge]

2. Science is king-Republicans wake UP!

[closeupready]

4. Wow, that's great news.

K&R

[Botany]

5. And who had been working on this from 2013?

Thanks Obama!

No doubt our liberal media will cover this good news 24/7.

[muriel_volestrangler]

8. Canada deserves the credit - their National Microbiology Laboratory developed & licensed it in 2010

Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NewLink Genetics Corporation (NASDAQ: NLNK), confirmed today that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has been initiated in Sierra Leone. The vaccine candidate was originally developed by the Public Health Agency of Canada’s National Microbiology Laboratory and licensed to NewLink Genetics in 2010. On Nov. 24, 2014, Merck and NewLink Genetics announced an exclusive licensing and collaboration agreement for the investigational Ebola vaccine.
...
Phase III study in Guinea: The World Health Organization (WHO), the Health Ministry of Guinea, Médecins sans Frontières (MSF), Epicentre and The Norwegian Institute of Public Health have initiated a safety and effectiveness study investigating Merck’s and NewLink’s rVSV-ZEBOV-GP, the vaccine candidate that was selected by the WHO and study partners to be assessed first in this study.

http://www.mercknewsroom.com/news-release/ebola-newsroom/phase-iii-trial-merck-and-newlink-genetics-investigational-ebola-vaccine

[Botany]

9. w/out a doubt canada deserves credit ....but Obama has been working on Ebola for 2 years now ...

... but it was used in the 2014 elections .... control ebola / secure the borders ....
and the day after the elections it was a non story w/our "liberal media."

[Politicub]

6. K&R because science is awesome

[restorefreedom]

7. certainly looks very promising

hope this is being publicly funded and not being done to turn a profit.

[FiveGoodMen]

11. Amen to that!

[NuclearDem]

13. Pharmaceutical companies don't make money on vaccines.

[PatrickforO]

10. Hey that's great. But, of course, if ebola breaks out here in the USA,

most of us WON'T HAVE ACCESS TO IT, because we have rationed healthcare.

[valerief]

17. +1000

[Cal Carpenter]

12. Oh my god that is incredible news.

[dbackjon]

14. Great, introduce Autism to Africa. Evil Vaccines.

(if needed)

[Cal Carpenter]

15. Honestly, you needed it

because I was about to flip the fuck out on you

[valerief]

16. Wonderful news. nt